Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01861847 · ClinicalTrials.gov registry record · Phase 2
7-Keto DHEA for the Treatment of PTSD
A Phase 2 study, sponsored by Humanetics Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
NCT01861847 is a Phase 2 study that has completed, run by Humanetics Corporation. The registered enrollment target is 71 participants.
The verdict
NCT01861847, a Phase 2 study, has completed, sponsored by Humanetics Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing symptoms of Post-Traumatic Stress Disorder (PTSD).
Interventions
- DRUG Placebo
- DRUG 7-Keto Dehydroepiandrosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01861847
The ClinicalTrials.gov registry entry for NCT01861847 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Humanetics Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01861847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01861847 about?
NCT01861847 is a clinical study titled "7-Keto DHEA for the Treatment of PTSD". The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing symptoms of Post-Traumatic Stress Disorder (PTSD).
What is the current status of trial NCT01861847?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2013-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01861847?
The interventions under investigation include: Placebo (DRUG), 7-Keto Dehydroepiandrosterone (DRUG).
Who is sponsoring clinical trial NCT01861847?
This trial is sponsored by Humanetics Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.